Regulation of apoptosis by adenovirus E1A and E1B oncogenes

Seminars in Virology

Volumn 8, Issue 6, 1998, Pages 505-513

  White, Eileen ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; PROTEIN BAX; PROTEIN P53; TRANSFORMING PROTEIN; TUMOR NECROSIS FACTOR ALPHA; VIRUS PROTEIN;

ADENOVIRUS; APOPTOSIS; CANCER; CELL CYCLE; ENZYME ACTIVATION; HUMAN; IMMUNOSURVEILLANCE; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; PROTEIN DEGRADATION; REVIEW; TUMOR SUPPRESSOR GENE; VIRUS INFECTION; VIRUS ONCOGENE;

EID: 0031755441     PISSN: 10445773     EISSN: None     Source Type: Journal    
DOI: 10.1006/smvy.1998.0155     Document Type: Article

References (106)

1. White E. Function of the adenovirus E1B oncogene in infected and transformed cells. Semin. Virol. 5:1994;341-348.
2. White E., Rao L., Chiou S.-K., Tseng C.-C., Sabbatini P., Gonzalez M., Verwaerde P. Regulation of apoptosis by the transforming gene products of adenovirus. Apoptosis. 1994;Plenum. p. 47-62.
3. White, E. Gooding, L. R. 1994, Regulation of apoptosis by human adenoviruses, In, Apoptosis: The Molecular Basis for Cell Death II, F. C. D. Tomei, 111, 141, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
4. Moran E. DNA tumor virus transforming proteins and the cell cycle. Curr. Opin. Genet. Dev. 3:1993;63-70.
5. White E., Sabbatini P., Debbas M., Wold W. S. M., Kusher D. I., Gooding L. The 19-kilodalton adenovirus E1B transforming protein inhibits programmed cell death and prevents cytolysis by tumor necrosis factor α Mol. Cell Biol. 12:1992;2570-2580.
6. Rao L., Debbas M., Sabbatini P., Hockenberry D., Korsmeyer S., White E. The adenovirus E1A proteins induce apoptosis which is inhibited by the E1B 19K and Bcl-2 proteins. Proc. Natl. Acad. Sci. USA. 89:1992;7742-7746.
7. White E. Regulation of apoptosis by the transforming genes of the DNA tumor virus adenovirus. Proc. Soc. Exp. Biol. Med. 204:1993;30-39.
8. White E., Cipriani R., Sabbatini P., Denton A. The adenovirus E1B 19-kilodalton protein overcomes the cytotoxicity of E1A proteins. J. Virol. 65:1991;2968-2978.
9. Pilder S., Moore M., Logan J., Shenk T. The adenovirus E1B 55K transforming polypeptide modulates transport or cytoplasmic stabilization of viral and host cell mRNAs. Mol. Cell Biol. 6:1986;470-476.
10. Subramanian T., Kuppuswamy M., Gysbers J., Mak S., Chinnadurai G. 19-kDa tumor antigen coded by early region E1b of adenovirus 2 is required for efficient synthesis and for protection of viral DNA. J. Biol. Chem. 259:1984;11777-11783.
11. Takemori N., Cladaras C., Bhat B., Conley A. J., Wold W. S. M. cyt gene of adenovirus 2 and 5 is an oncogene for transforming function in early region E1B and encodes the E1B 19,000-molecular-weight polypeptide. J. Virol. 52:1984;793-805.
12. White E., Grodzicker T., Stillman B. W. Mutations in the gene encoding the adenovirus E1B 19K tumor antigen cause degradation of chromosomal DNA. J. Virol. 52:1984;410-419.
13. Chiou S.-K., White E. p300 binding by E1A cosegregates with p53 induction but is dispensable for apoptosis. J. Virol. 71:1997;3515-3525.
14. Mymryk J. S., Shire K., Bayley S. T. Induction of apoptosis by adenovirus type 5 E1A in rat cells requires a proliferation block. Oncogene. 9:1994;1187-1193.
15. Teodoro J. G., Shore G. C., Branton P. E. Adenovirus E1A proteins induce apoptosis by both p53-dependent and p53-independent mechanisms. Oncogene. 11:1995;467-474.
16. Dyson N., Harlow E. Adenovirus E1A targets key regulators of cell proliferation. Cancer Surv. 12:1992;161-195.
17. Chiou S.-K., Tseng C. C., Rao L., White E. Functional complementation of the adenovirus E1B 19K protein with Bcl-2 in the inhibition of apoptosis in infected cells. J. Virol. 68:1994;6553-6566.
18. Han J., Sabbatini P., Perez D., Rao L., Modha D., White E. The E1B 19K protein blocks apoptosis by interacting with and inhibiting the p53-inducible and death-promoting Bax protein. Genes Dev. 10:1996;461-477.
19. Chen G., Branton P. E., Yang E., Korsmeyer S. J., Shore G. C. Adenovirus E1B 19-kDa death suppressor protein interacts with Bax but not with Bad. J. Biol. Chem. 271:1996;24221-24225.
20. Han J., Sabbatini P., White E. Induction of apoptosis by human Nbk/Bik, a BH3 containing E1B 19K interacting protein. Mol. Cell Biol. 16:1996;5857-5864.
21. Farrow S. N., White J. H. M., Martinou I., Raven T., Pun K.-T., Grinham C. J., Martinou J.-C., Brown R. Cloning of a bcl-2 homologue by interaction with adenovirus E1B 19K. Nature (London). 374:1995;731-733.
22. Han J., Modha D., White E. Interaction of E1B 19K with Bax is required to block Bax-induced loss of mitochondrial membrane potential and apoptosis. Oncogene. 1998.
23. Rao L., Modha D., White E. The E1B 19K protein associates with lamins in vivo and its proper localization is required for inhibition of apoptosis. Oncogene. 15:1997;1587-1597.
24. Boyd J., Malstrom S., Subramanian T., Venkatesh L., Schaeper U., Elangovan B., D'Sa-Eipper C., Chinnadurai G. Adenovirus E1B 19kDa and bcl-2 proteins interact with a common set of cellular proteins. Cell. 79:1994;341-351.
25. Wolter K. G., Hsu Y.-T., Smith C. L., Nechushtan A., Xi X.-G. Movement of Bax from the cytosol to mitochondria during apoptosis. J. Cell Biol. 139:1997;1281-1292.
26. L. Nature (London). 385:1997;353-357.
27. Schendel S. L., Xie Z., Montal M. O., Matsuyama S., Montal M. Channel formation by antiapoptotic protein Bcl-2. Proc. Natl. Acad. Sci. USA. 94:1997;5113-5118.
28. L. Nature (London). 381:1996;335-341.
29. Li P., Nijihawan D., Budihardjo I., Srinivasula S. M., Ahmad M., Alnemri E. S., Wang X. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell. 91:1997;479-489.
30. Liu X., Kim C. N., Yang J., Jemmerson R., Wang X. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell. 86:1996;147-157.
31. McCarthy N. J., Whyte M. K. B., Gilbert C. S., Evan G. I. Inhibition of Ced-3/ICE-related proteases does not prevent cell death induced by oncogenes, DNA damage, or the Bcl-2 homologue Bak. J. Cell Biol. 136:1997;215-227.
32. White E., Blose S. H., Stillman B. Nuclear envelope localization of an adenovirus tumor antigen maintains the integrity of cellular DNA. Mol. Cell Biol. 4:1984;2865-2875.
33. White E., Cipriani R. Specific disruption of intermediate filaments and the nuclear lamina by the 19-kDa product of the adenovirus E1B oncogene. Proc. Natl. Acad. Sci. USA. 86:1989;9886-9890.
34. White E., Cipriani R. Role of adenovirus E1B proteins in transformation: Altered organization of intermediate filaments in transformed cells that express the 19-kilodalton protein. Mol. Cell Biol. 10:1990;120-130.
35. L. Nature (London). 379:1996;554-556.
36. Yuan J., Shaham S., Ledoux S., Ellis H. M., Horvitz H. R. TheC. elegans. Cell. 75:1993;641-652.
37. Xue D., Shaham S., Horvitz H. R. TheCaenorhabditis elegans. Genes Dev. 10:1996;1073-1083.
38. Salvesen G. S., Dixit V. M. Caspases: Intracellular signaling by proteolysis. Cell. 91:1997;443-446.
39. Boulakia C. A., Chen G., Ng F. W. H., Teodoro J. G., Branton P. E., Nicholson D. W., Poirier G. G., Shore G. C. Bcl-2 and adenovirus E1B 19 kDa protein prevent E1A-induced processing of CPP32 and cleavage of poly(ADP-ribose) polymerase. Oncogene. 12:1996;529-535.
40. Chiou S.-K., White E. Inhibition of ICE-like proteases inhibits apoptosis and increases virus production during adenovirus infection. Virology. 244:1998;108-118.
41. Rao L., Perez D., White E. Lamin proteolysis facilitates nuclear events during apoptosis. J. Cell Biol. 135:1996;1441-1455.
42. Sabbatini P., Han J. H., Chiou S.-K., Nicholson D., White E. Interleukin 1β converting enzyme-like proteases are essential for p53-mediated transcriptionally dependent apoptosis. Cell Growth Differ. 8:1997;643-653.
43. White E., Faha B., Stillman B. Regulation of adenovirus gene expression in human WI38 cells by an E1B-encoded tumor antigen. Mol. Cell Biol. 6:1986;3763-3773.
44. White E., Stillman B. Expression of the adenovirus E1B mutant phenotypes is dependent on the host cell and on synthesis of E1A proteins. J. Virol. 61:1987;426-435.
45. Chinnadurai G. Adenovirus 2 lp+ locus codes for a 19K tumor antigen that plays an essential role in cell transformation. Cell. 33:1983;759-766.
46. Debbas M., White E. Wild-type p53 mediates apoptosis by E1A which is inhibited by E1B. Genes Dev. 7:1993;546-554.
47. Lowe S., Ruley H. E. Stabilization of the p53 tumor suppressor is induced by adenovirus-5 E1A and accompanies apoptosis. Genes Dev. 7:1993;535-545.
48. Querido E. J., Teodoro J. G., Branton P. E. Accumulation of p53 induced by the adenovirus E1A protein requires regions involved in the stimulation of DNA synthesis. J. Virol. 71:1997;3526-3533.
49. Sanchez-Prieto R., Lleonart M., Cajal S. Lack of correlation between p53 protein level and sensitivity to DNA-damaging agents in keratinocytes carrying adenovirus E1A mutants. Oncogene. 11:1995;675-682.
50. Arany Z., Sellers W., Livingston D., Eckner R. E1A-associated p300 and CREB-associated CBP belong to a conserved family of coactivators. Cell. 77:1994;799-800.
51. Lundblad J. R., Kwok R. P., Laurance M. E., Harter M. L., Goodman R. H. Adenoviral E1A-associated protein p300 as a functional homologue of the transcriptional co-activator CBP. Nature (London). 374:1995;85-88.
52. Ogryzko V. V., Schiltz R. L., Russanova V., Howard B. H., Nakatani Y. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell. 87:1996;953-959.
53. Bannister A. J., Kouzarides T. The CBP coactivator is a histone acetyltransferase. Nature (London). 384:1996;641-643.
54. Prives C. How loops, β sheets, and α helices help us to understand p53. Cell. 78:1994;543-546.
55. Ko L. J., Prives C. p53: Puzzle and paradigm. Genes Dev. 10:1996;1054-1072.
56. Levine A. J. p53, the cellular gatekeeper for growth and division. Cell. 88:1997;323-331.
57. Sabbatini P., Lin J., Levine A. J., White E. Essential role for p53-mediated transcription in apoptosis but not growth suppression. Genes Dev. 9:1995;2184-2192.
58. Attardi L. D., Lowe S. W., Brugarolas J., Jacks T. Transcriptional activation by p53, but not induction of the p21 gene, is essential for oncogene-mediated apoptosis. EMBO J. 15:1996;3693-3701.
59. Miyashita T., Reed J. C. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell. 80:1995;293-299.
60. Sakamuro D., Sabbatini P., White E., Prendergast G. C. The polyproline region of p53 is required to activate apoptosis but not growth arrest. Oncogene. 15:1997;887-898.
61. Walker K. K., Levine A. J. Identification of a novel p53 functional domain that is necessary for efficient growth suppression. Proc. Natl. Acad. Sci. USA. 93:1996;15335-15340.
62. McCurrach M. E., Connor T. M. F., Knudson C. M., Korsmeyer S. J., Lowe S. W. bax-deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis. Proc. Natl. Acad. Sci. USA. 94:1997;2345-2349.
63. Yin C., Knudson C. M., Korsmeyer S. J., Van Dyke T. Bax suppresses tumorigenesis and stimulates apoptosis in vivo. Nature (London). 385:1997;637-640.
64. Barak Y., Juven T., Haffner R., Oren M. mdm2 expression is induced by wild type p53 activity. EMBO J. 12:1993;461-468.
65. Chen J., Wu X., Lin J., Levine A. J. mdm-2 inhibits the G1 arrest and apoptosis functions of the p53 tumor suppressor protein. Mol. Cell Biol. 16:1996;2445-2452.
66. Haupt Y., Maya R., Kazaz A., Oren M. Mdm2 promotes the rapid degradation of p53. Nature (London). 387:1997;296-299.
67. Kubbutat M. H. G., Jones S. N., Vousden K. H. Regulation of p53 stability by Mdm2. Nature (London). 387:1997;299-303.
68. Lin J., Chen J., Elenbaas B., Levine A. J. Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein. Genes Dev. 8:1994;1235-1246.
69. Momand J., Zambetti G. P., Olson D. C., George D., Levine A. J. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell. 69:1992;1237-1245.
70. Oliner J. D., Pietenpol J., Thiagalingam S., Gyuris J., Kinzler K. W., Vogelstein B. Oncoprotein MDM2 conceals the activation domain of tumor suppressor p53. Nature (London). 362:1993;857-860.
71. Jones S. N., Roe A. E., Donehower L. A., Bradley A. Resue of embryonic lethality in Mdm2-deficient mice by absence of p53. Nature (London). 378:1995;206-208.
72. Montes de Oca Luna R., Wagner D. S., Lozano G. Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature (London). 378:1995;203-206.
73. Wu X., Bayle J. H., Olson D., Levine A. J. The p53-mdm-2 autoregulatory feedback loop. Genes Dev. 7:1993;1126-1132.
74. Avantaggiati M. L., Ogryzko V., Gardner K., Giordano A., Levine A. S., Kelly K. Recruitment of p300-CBP in p53-dependent signal pathways. Cell. 89:1997;1175-1184.
75. Lill N. L., Grossman S. R., Ginsberg D., DeCaprio J., Livingston D. M. Binding and modulation of p53 by p300/CBP coactivators. Nature (London). 387:1997;823-827.
76. Scolnick D. M., Chehab N. H., Stavridi E. S., Lien M. C., Caruso L., Moran E., Berger S. L., Halazonetis T. D. CREB-binding protein and p300-CBP-associated factor are transcriptional coactivators of the p53-tumor suppressor protein. Cancer Res. 57:1997;3693-3696.
77. Thomas A., White E. Suppression of the p300-dependent mdm2 negative-feedback loop induces the p53 apoptotic function. Genes Dev. 1998.
78. Chen X., Ko L. J., Jayaraman L., Prives C. p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells. Genes Dev. 10:1996;2438-2451.
79. Chiou S.-K., Rao L., White E. Bcl-2 blocks p53-dependent apoptosis. Mol. Cell Biol. 14:1994;2556-2563.
80. L. Oncogene. 11:1995;1389-1394.
81. Yoshida K., Venkatesh L., Kuppuswamy M., Chinnadurai G. Adenovirus transforming 19-kD T antigen has an enhancer dependent transactivation function and relieves enchancer repression mediated by viral and cellular genes. Genes Dev. 1:1987;645-658.
82. Stein R. W., Corrigan M., Yaciuk P., Whelan J., Moran E. Analysis of E1A-mediated growth regulation functions: Binding of the 300-kilodalton cellular product correlates with E1A repression function and DNA synthesis-inducing activity. J. Virol. 64:1991;4421-4427.
83. Lee J. S., Galvin K. M., See R. H., Eckner R., Livingston D., Moran E., Shi Y. Relief of YY1 transcriptional repression by adenovirus E1A is mediated by E1A-associated protein p300. Genes Dev. 9:1995;1188-1198.
84. Sabbatini P., Chiou S.-K., Rao L., White E. Modulation of p53-mediated transcription and apoptosis by the adenovirus E1B 19K protein. Mol. Cell Biol. 15:1995;1060-1070.
85. Shen Y., Shenk T. Relief of p53 mediated transcriptional repression by the adenovirus E1B 19-kDa protein or the cellular Bcl-2 protein. Proc. Natl. Acad. Sci. USA. 91:1994;8940-8944.
86. McKeon F. Nuclear lamin proteins: Domains required for nuclear targeting, assembly, and cell-cycle-regulated dynamics. Curr. Opin. Cell Biol. 3:1991;82-86.
87. Neamati N., Fernandez A., Wright S., Kiefer J., McConkey D. J. Degradation of lamin B1 precedes oligonucleosomal DNA fragmentation in apoptotic thymocytes and isolated thymocyte nuclei. J. Immunol. 154:1995;3788-3795.
88. Oberhammer F. A., Hochegger K., Froschl G., Tiefenbacher R., Pavelka M. Chromatin condensation during apoptosis is accompanied by degradation of lamin A + B, without enhanced activation of cdc2 kinase. J. Cell Biol. 126:1994;827-837.
89. Orth K., Chinnaiyan A. M., Garg M., Froelich C. J., Dixit V. M. The CED-3/ICE-like protease Mch2 is activated during apoptosis and cleaves the death substrate lamin A. J. Biol. Chem. 271:1996;16443-16446.
90. Takahashi A., Alnemri E. S., Lazebnik Y. A., Fernandes-Alnemri T., Litwack G., Moir R. D., Goldman R. D., Poirier G. G., Kaufmann S. H., Earnshaw W. C. Cleavage of lamin A by Mch2α but not CPP32: Multiple interleukin 1 β-converting enzyme-related proteases with distinct substrate recognition properties are active in apoptosis. Proc. Natl. Acad. Sci. USA. 93:1996;8395-8400.
91. Enari M., Sakahira H., Yokoyama H., Okawa K., Iwanatsu A., Natata S. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature (London). 391:1998;43-50.
92. Sakahira H., Enari M., Nagata S. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature (London). 391:1998;96-99.
93. Kothakota S., Azuma T., Reinhard C., Klippel A., Tang J., Chu K., McGarry T. J., Kirschner M. W., Koths K., Kwiatkowski D. J., Williams L. T. Caspase-3-generated fragment of gelsolin: Effector of morphological change in apoptosis. Science. 278:1997;294-298.
94. Boldin M. P., Goncharov T. M., Goltsev Y. V., Wallach D. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell. 85:1996;803-815.
95. Chinnaiyan A. M., Tepper C. G., Seldin M. F., O'Rourke K., Kischkel F. C., Hellbardt S., Krammer P. H., Peter M. E., Dixit V. M. FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J. Biol. Chem. 271:1996;4961-4965.
96. Hashimoto S., Ishii A., Yonehara S. The E1B oncogene of adenovirus confers cellular resistance to cytotoxicity of tumor necrosis factor and monoclonal anti-Fas antibody. Int. Immunol. 3:1991;343-351.
97. Nagata S. Apoptosis by death factor. Cell. 88:1997;355-365.
98. Perez D., White E. E1B 19K inhibits Fas-mediated apoptosis through FADD-dependent sequestration of FLICE. J. Cell Biol. 141:1998;1255-1266.
99. Chinnaiyan A. M., O'Rourke K., Lane B. R., Dixit V. M. Interaction of CED-4 with CED-3 and CED-9: a molecular framework for cell death. Science. 275:1997;1122-1126.
100. Chinnaiyan A. M., Chaudhary D., O'Rourke K., Koonin E. V., Dixit V. M. Role of CED-4 in the activation of CED-3. Nature (London). 388:1997;728-729.
101. Seshagiri S., Miller L. K. Caenorhabditis elegans. Curr. Biol. 7:1997;455-460.
102. Spector M. S., Desnoyers S., Hoeppner D. J., Hengartner M. O. Interaction between theC. elegans. Nature (London). 385:1997;653-656.
103. Wu D., Wallen H. D., Nuñez G. Interaction and regulation of subcellular localization of CED-4 by CED-9. Science. 275:1997;1126-1128.
104. Wu D., Wallen H. D., Inohara N., Nuñez G. Interaction and regulation of theCaenorhabditis elegans. J. Biol. Chem. 272:1997;21449-21454.
105. Zou H., Henzel W. J., Liu X., Lutschg A., Wang X. Apaf-1, a human protein homologous toC. elegans. Cell. 90:1997;405-413.
106. Han, J. Wu, D. Nunez, G. White, E. 1998, E1B 19K-CED-4 functional interaction.